Haemonetics Corporation
DE ˙ DB ˙ US4050241003
59,00 € ↑3,00 (5,36%)
2026-06-04
AKTIENPREIS
SecurityDE:HAZ / Haemonetics Corporation
InstitutionFmr Llc
Latest Disclosed Ownership1,275,886 shares
Latest Disclosed Value $ 71,908,935
Fmr Llc reports 3.84% decrease in ownership of HAZ / Haemonetics Corporation

On May 15, 2026 - Fmr Llc filed a 13F-HR form disclosing ownership of 1,275,886 shares of Haemonetics Corporation (DE:HAZ) valued at $61,242,528 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 1,326,902 shares of Haemonetics Corporation. This represents a change in shares of -3.84% during the quarter. The current value of the position is $75,277,274 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F HAEMONETICS CORP MASS COM 405024100 1,275,886 -51,016 -3.84 71,909 -32.39 0.0008
2026-02-17 2025-12-31 13F HAEMONETICS CORP MASS COM 405024100 1,326,902 111,073 9.14 106,351 79.47 0.0054
2025-11-13 2025-09-30 13F HAEMONETICS CORP MASS COM 405024100 1,215,829 379,982 45.46 59,260 -4.98 0.0031
2025-08-14 2025-06-30 13F HAEMONETICS CORP MASS COM 405024100 835,847 -7,409 -0.88 62,363 16.37 0.0035
2025-05-12 2025-03-31 13F HAEMONETICS CORP MASS COM 405024100 843,256 46,509 5.84 53,589 -13.86 0.0034
2025-02-13 2024-12-31 13F HAEMONETICS CORP MASS COM 405024100 796,747 22,218 2.87 62,210 -0.07 0.0037
2024-11-13 2024-09-30 13F HAEMONETICS CORP MASS COM 405024100 774,529 521,640 206.27 62,257 197.58 0.0038
2024-08-13 2024-06-30 13F HAEMONETICS CORP MASS COM 405024100 252,889 56,560 28.81 20,922 24.86 0.0013
2024-05-13 2024-03-31 13F HAEMONETICS CORP MASS COM 405024100 196,329 -1,384,464 -87.58 16,757 -87.60 0.0011
2024-02-13 2023-12-31 13F HAEMONETICS CORP MASS COM 405024100 1,580,793 -39,758 -2.45 135,174 -6.89 0.0104
2023-11-13 2023-09-30 13F HAEMONETICS CORP MASS COM 405024100 1,620,551 -415,740 -20.42 145,169 -16.27 0.0125
2023-08-11 2023-06-30 13F HAEMONETICS CORP MASS COM 405024100 2,036,291 171,345 9.19 173,370 12.34 0.0145
2023-08-11 2023-03-31 13F/A-1 HAEMONETICS CORP MASS COM 405024100 1,864,946 631,387 51.18 154,324 59.07 0.0141
2023-05-11 2023-03-31 13F HAEMONETICS CORP MASS COM 405024100 1,864,946 631,387 154,324 0.0028
2023-02-13 2022-12-31 13F HAEMONETICS CORP MASS COM 405024100 1,233,559 600,554 94.87 97,019 107.04 0.0096
2022-11-10 2022-09-30 13F HAEMONETICS CORP MASS COM 405024100 633,005 240,357 61.21 46,861 83.10 0.0049
2022-08-12 2022-06-30 13F HAEMONETICS CORP MASS COM 405024100 392,648 389,727 13,342.25 25,593 13,809.24 0.0026
2022-05-13 2022-03-31 13F HAEMONETICS CORP MASS COM 405024100 2,921 1,032 54.63 184 84.00 0.0000
2022-02-14 2021-12-31 13F HAEMONETICS CORP MASS COM 405024100 1,889 -5,851 -75.59 100 -81.68 0.0000
2022-02-14 2021-09-30 13F/A-1 HAEMONETICS CORP MASS COM 405024100 7,740 -403 -4.95 546 0.55 0.0000
2021-11-15 2021-09-30 13F HAEMONETICS CORP MASS COM 405024100 7,740 -403 546 0.0000
2021-08-13 2021-06-30 13F HAEMONETICS CORP MASS COM 405024100 8,143 -2,242,941 -99.64 543 -99.78 0.0000
2021-05-14 2021-03-31 13F HAEMONETICS CORP MASS COM 405024100 2,251,084 -232,570 -9.36 249,893 -15.27 0.0213
2021-02-08 2020-12-31 13F HAEMONETICS COM 405024100 2,483,654 228,955 10.15 294,934 49.92 0.0262
2020-11-13 2020-09-30 13F HAEMONETICS COM 405024100 2,254,699 467,845 26.18 196,722 22.93 0.0199
2020-08-24 2020-06-30 13F/A-1 HAEMONETICS COM 405024100 1,786,854 64,110 3.72 160,031 -6.79 0.0176
2020-08-13 2020-06-30 13F HAEMONETICS COM 405024100 1,786,854 64,110 160,031 3,931.4934
2020-05-14 2020-03-31 13F HAEMONETICS COM 405024100 1,722,744 -399,567 -18.83 171,689 -29.59 0.0238
2020-02-07 2019-12-31 13F HAEMONETICS COM 405024100 2,122,311 229,602 12.13 243,853 2.14 0.0269
2019-11-13 2019-09-30 13F HAEMONETICS COM 405024100 1,892,709 1,131,195 148.55 238,747 160.52 0.0286
2019-08-13 2019-06-30 13F HAEMONETICS COM 405024100 761,514 756,633 15,501.60 91,641 21,361.59 0.0107
2019-05-13 2019-03-31 13F HAEMONETICS COM 405024100 4,881 22 0.45 427 -12.14 0.0001
2019-02-13 2018-12-31 13F HAEMONETICS COM 405024100 4,859 -74 -1.50 486 -13.98 0.0001
2018-11-09 2018-09-30 13F HAEMONETICS COM 405024100 4,933 -7,038 -58.79 565 -47.39 0.0001
2018-08-10 2018-06-30 13F HAEMONETICS COM 405024100 11,971 5,971 99.52 1,074 144.65 0.0001
2018-05-14 2018-03-31 13F HAEMONETICS COM 405024100 6,000 -23,263 -79.50 439 -74.18 0.0001
2018-02-12 2017-12-31 13F HAEMONETICS COM 405024100 29,263 -4,818 -14.14 1,700 11.18 0.0002
2017-11-13 2017-09-30 13F HAEMONETICS COM 405024100 34,081 76 0.22 1,529 13.93 0.0002
2017-08-29 2017-06-30 13F/A-1 HAEMONETICS COM 405024100 34,005 -391 -1.14 1,342 -3.80 0.0002
2017-08-11 2017-06-30 13F HAEMONETICS COM 405024100 34,005 -391 1,342
2017-05-11 2017-03-31 13F HAEMONETICS COM 405024100 34,396 -142,428 -80.55 1,395 -80.37 0.0002
2017-02-10 2016-12-31 13F HAEMONETICS COM 405024100 176,824 -924,764 -83.95 7,108 -82.18 0.0010
2016-11-14 2016-09-30 13F HAEMONETICS COM 405024100 1,101,588 -255,491 -18.83 39,889 1.39 0.0053
2016-08-11 2016-06-30 13F HAEMONETICS COM 405024100 1,357,079 0 0.00 39,342 -17.12 0.0054
2016-05-16 2016-03-31 13F HAEMONETICS COM 405024100 1,357,079 -573,212 -29.70 47,470 -23.72 0.0066
2016-02-12 2015-12-31 13F HAEMONETICS COM 405024100 1,930,291 2,365 0.12 62,233 -0.12 0.0084
2015-11-10 2015-09-30 13F HAEMONETICS COM 405024100 1,927,926 -348,676 -15.32 62,310 -33.83 0.0089
2015-08-25 2015-06-30 13F/A-1 HAEMONETICS COM 405024100 2,276,602 -14,668 -0.64 94,160 -8.51 0.0121
2015-08-13 2015-06-30 13F HAEMONETICS COM 405024100 2,276,602 94,160
2015-05-14 2015-03-31 13F HAEMONETICS COM 405024100 2,291,270 8,000 0.35 102,923 20.46 0.0131
2015-02-17 2014-12-31 13F HAEMONETICS COM 405024100 2,283,270 -273,714 -10.70 85,440 -4.31 0.0111
2014-11-14 2014-09-30 13F HAEMONETICS COM 405024100 2,556,984 -54,990 -2.11 89,290 -3.10 0.0121
2014-08-14 2014-06-30 13F HAEMONETICS COM 405024100 2,611,974 379,174 16.98 92,150 26.64 0.0124
2014-05-15 2014-03-31 13F HAEMONETICS COM 405024100 2,232,800 1,481,240 197.09 72,767 129.82 0.0101
2014-02-13 2013-12-31 13F HAEMONETICS COM 405024100 751,560 -43,248 -5.44 31,663 -0.10 0.0045
2013-11-14 2013-09-30 13F HAEMONETICS COM 405024100 794,808 -332,820 -29.52 31,696 -32.02 0.0049
2013-09-24 2013-06-30 13F/A-1 HAEMONETICS COM 405024100 1,127,628 1,127,628 46,627 0.0076
2013-08-14 2013-06-30 13F HAEMONETICS COM 405024100 1,127,628 46,627 0.0076
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.